Loading

Synthesis, Characterization, Biological Activity and Thermal Studies of Trimethoprim Metal Complexes

Research Article | Open Access | Volume 6 | Issue 1

  • 1. Department of Chemistry, Alexandria University, Egypt
  • 2. Department of Chemistry, Damanhour University, Egypt
+ Show More - Show Less
Corresponding Authors
Gomaa E. Amer, Department of Chemistry, Faculty of Science, Damanhour University, Egypt
Abstract

Nine complexes of trimethoprim with some transition metals [Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Cu(II), Zn(II), Cd(II) and Hg(II)] were synthesized and characterized by elemental analysis, IR, electronic spectra and magnetic measurements. The IR spectra proved that trimethoprim act as a bidentate ligand. From the electronic spectra and magnetic measurements, all complexes have octahedral geometry. The antimicrobial activity examined against two grampositive and two gram-negative bacteria. The complexes showed a well antifungal activity. The thermal decomposition mechanisms of trimethoprim and its metal complexes were studied and suggested from the DTA and TGA curves. All complexes were thermally decomposed and ended by formation of the metal oxides except the complex of mercury.

Keywords

•    Trimethoprim; Complexes; Synthesis; Biological 
activity; Thermal Studies

Citation

Masoud MS, Ali AE, Elasala GS, Amer GE (2019) Synthesis, Characterization, Biological Activity and Thermal Studies of Trimethoprim Metal Complexes. J Drug Des Res 6(1): 1074.

INTRODUCTION

Trimethoprim, chemically 5-(3,4,5-trimethoxybenzyl) pyrimidine-2,4-diamine, it is composed of two parts: 3,4,5-trimethoxytoluene and 2,4-diamino-5-methylpyrimidine (Figure 1).

Chemical Structure of Trimethoprim (TMP).

Figure 1: Chemical Structure of Trimethoprim (TMP).

It is one of the chemotherapeutic agents known as dihydrofolate reductase inhibitors. It is used in prophylaxis treatment and urinary tract infections [1].

Trimethoprim is a synthetic antibacterial combination product. It is considered as bacteriostatic antibiotic. It acts by interfering with the action of bacterial dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. This is an essential precursor in the de novo synthesis of the intermediate thymidine monophosphate, a precursor of DNA metabolite thymidine triphosphate [2].

Bacteria are unable to take up folic acid from the environment and are thus dependent on their own synthesis. Inhibition of the enzyme deprives the bacteria of nucleotides which are necessary for DNA replication causing, in certain circumstances, cell lethality. Trimethoprim combination with sulphadimidine antibiotic inhibits an earlier step in the folate synthesis pathway (Figure 2).

Mechanism of action of trimethoprim..

Figure 2: Mechanism of action of trimethoprim..

This combination results in an in-vitro synergistic antibacterial effect by inhibiting successive steps in folate synthesis. This benefit was not seen in general clinical use [3]. Trimethoprim has higher antimicrobial activity against gram-positive and gram-negative bacteria and antifungal activity against different fungi. Previous work for trimethoprim metal complexes fell to synthesis of trimethoprim complexes with (Fe, Cu, Zn and Pt) [4]. In this study the coordination properties of trimethoprim metal complexes were discussed and identified by IR, UV-Vis, ESR and magnetic susceptibility measurements. The thermal behavior of trimethoprim and its metal complexes were discussed from the TGA and DTA curves. The proposed mechanism of decomposition is discussed. Also the thermodynamic and kinetic parameters were calculated. The biological activity of the ligand and its complexes aimed to be studied.

EXPERIMENTAL PART

The solution of trimethoprim was prepared by dissolving the solid in hot ethanol, while the solutions of the salts [Cr(III), Mn(II), Fe(III), Co(II), Ni(II), Cu(II), Zn(II), Cd(II) and Hg(II)] as chlorides were prepared by dissolving the salt in 50 ml distilled water. The solution of trimethoprim was mixed with the aqueous solution of the metal chloride with molar ratio (1:1). The reaction mixture was refluxed for about 45 min then left overnight. The obtained precipitates were isolated by filtration, and then washed by EtOH-H2O and dried in a vacuum desiccator over anhydrous CaCl2.

Table 1: Elemental analysis, m.p. and color of trimethoprim metal complexes.

Complexes Color Calculated/(Found)%
C H N M Cl
[Cr(TMP)Cl2(OH)H2O]. H2O Pale blue 36.06 (36.11) 4.97 (4.93) 12.02 (12.11) 11.15 (11.21) 15.21 (15.18)
[Mn(TMP)2Cl2].H2O Buff 46.42 (46.47) 5.29 (5.32) 15.47 (15.41) 7.58 (7.49) 9.79 (9.63)
[Fe(TMP)Cl2(OH)H2O].2H2O Pale brown 34.45 (34.48) 5.16 (5.12) 11.48 (11.43) 11.44 (11.46) 14.53 (14.54)
[Co(TMP)2Cl2].3H2O Pale pink 43.99 (44.03) 5.54 (5.49) 14.66 (14.59) 7.71 (7.76) 9.27 (9.22)
[Ni(TMP)2Cl2].H2O Green 46.18 (46.21) 5.26 (5.28) 15.39 (15.36) 8.06 (8.12) 9.74 (9.81)
[Cu(TMP)2Cl2].H2O Pale green 45.87 (45.91) 5.22 (5.19) 15.28 (15.25) 8.67 (8.58) 9.67 (9.63)
[Zn(TMP)2Cl2].H2O Colorless 45.76 (45.71) 5.21 (5.26) 15.25 (15.19) 8.90 (8.98) 9.65 (9.59)
[Cd(TMP)2Cl2].H2O Pale yellow 43.01 (43.06) 4.90 (4.88) 14.33 (14.28) 14.38 (14.40) 9.07 (9.13)
[Hg(TMP)2Cl2].H2O White 38.65 (38.58) 4.40 (4.42) 12.88 (12.90) 23.05 (22.96) 8.15 (8.08)
The melting point of the all prepared complexes is higher than 300º C

The analytical data (Table 1), of the prepared complexes examined by usual methods [5]. The chloride contents of the complexes were analyzed by using Volhard method [6]. Also the contents of metals were determined by using atomic absorption spectroscopy and complexometric analysis [7].

MEASUREMENTS

The electronic spectra of the solid metal complexes were measured in Nujol mull spectra by use Unicam UV/Vis spectrometer [8]. The IR spectra of the trimethoprim and its metal complexes were recorded on Perkin Elmer spectrophotometer, Model 1430 which it is range of 400-4000 cm-1. The Molar magnetic susceptibilities were determined by using Pascal’s constants at room temperature using Faraday’s method. The electron spin resonance spectra were recorded on reflection spectrometer operating at (9.1–9.8) GHZ in a cylindrical resonance cavity with 100 KHZ modulation. The values of g were determined by comparison with the standard DPPH signal. Differential thermal analysis and thermogravimetric analysis of the ligand and its complexes were recorded on Shimadzu DTA/TGA-60 thermal analyzer with heating rate 10°C/min under nitrogen atmosphere of flow rate 20 ml/min. The biological activity of trimethoprim and its complexes were examined against five microorganisms representing different microbial categories, two Gram-positive (Staphylococcus Aureas ATCC6538P and Bacillus subtilis ATCC19659), two Gram negative (Escherischia coli ATCC8739 strain and Pseudomonas aeruginosa ATCC9027) and candida albicans as a fungi.

RESULTS AND DISCUSSION

The IR of trimethoprim and its metal complexes are listed in (Table 2) with some important characteristic assignments.

Table 2: Fundamental infrared bands of trimethoprim (cm-1) and its metal complexes.

Compounds ν NH2 vC=N νM-N νM-O νM-Cl
TMP 3469 1636 …… …… ……
[Cr(TMP)Cl2 (OH)H2 O].H2 O 3406 1675 507 470 430
[Mn(TMP)2 Cl2 ].H2 O 3405 1674 518 …… 438
[Fe(TMP)Cl2 (OH)H2 O].2H2 O 3402 1670 519 466 435
[Co(TMP)2 Cl2 ].3H2 O 3405 1675 507 …… 420
[Ni(TMP)2 Cl2 ].H2 O 3405 1674 517 …… 425
[Cu(TMP)2 Cl2 ].H2 O 3405 1674 518 …… 431
[Zn(TMP)2 Cl2 ].H2 O 3428 1673 528 …… 438
[Cd(TMP)2 Cl2 ].H2 O 3415 1670 577   435
[Hg(TMP)2 Cl2 ].H2 O 3408 1623 575 …… 430
Electronic spectra and magnetic studies

Trimethoprim showed characteristic bands at 3469, 3317 and 1636 cm-1 mainly due to the asymmetric νNH2, symmetric νNH2 and νC=N pyrimidine ring vibrations, respectively. The metal complexes also contained other bands which are indication of the coordination of the ligand with the metal ions. The asymmetric νNH2 band appeared at 3469 cm-1 in the spectrum of trimethoprim, this band and the νC=N pyrimidine ring band shifted for trimethoprim metal complexes. Spectral studies of all synthesized trimethoprim metal complexes indicated that the linking of the organic molecule with the metal ions as a bidentate ligand through the nitrogen atom N(7) of the amino group and the nitrogen atom N(2) of the pyrimidine ring. For [Cr(TMP)Cl2 (OH)H2O].H2O complex, the coordination occurred through the nitrogen atom of amino group which was indicated by shifting of νNH2 from 3469 cm-1 to 3406 cm-1 and the nitrogen atom of pyrimidine ring which was indicated by shifting of νC=N from 1636 to 1675 cm-1, Table 2, besides appearance of νM-N stretching at 507 cm-1, νM-O stretching at 490 cm-1 [9], and νMCl at 450 cm-1, Table 2. For the complex [Mn(TMP)2Cl2].H2O, the shift in the amino group from 3469 to 3405 cm-1 and the change in the value of νC=N of from 1636 to 1674 cm-1, Table 2, indicated that the coordination occurred through the nitrogen atoms of amino group and of pyrimidine ring, so the ligand acts as bidentate, in addition to appearance of bands at 518 cm-1 and 465 cm-1, Table 2, represents νM-N stretching and νM-Cl respectively. Similar situations are evident for all the other complexes Table 2. The electronic absorption spectra for the chromium complex [Cr(TMP)Cl2OHH2O].H2O showed three bands at 295, 405, 600 nm due to 4A2g→4T1g (P), 4A2g→4T1g(F) and 4A2g→4T2g(F) transitions, respectively (Table 3).

Table 3: Nujol mull electronic absorption spectra λ max (nm), room temperature effective magnetic moment values (µeff, 298° K) and geometries of trimethoprim metal complexes.

Complex λ max (nm) µ eff (B.M) Geometry
[Cr(TMP)Cl2 (OH)H2 O].H2 O 295, 405, 600 4.71 Oh
[Mn(TMP)2 Cl2 ].H2 O 310, 353, 500 4.30 Oh
[Fe(TMP)Cl2 (OH)H2 O].2H2 O 258, 350, 483 4.26 Oh
[Co(TMP)2 Cl2 ].3H2 O 294, 473, 558 5.13 Oh
[Ni(TMP)2 Cl2 ].H2 O 381, 480, 625 2.80 Oh
[Cu(TMP)2 Cl2 ].H2 O 260, 410, 720 2.09 Oh
[Zn(TMP)2 Cl2 ].H2 O .......... Diamagnetic Oh
[Cd(TMP)2 Cl2 ].H2 O .......... Diamagnetic Oh
[Hg(TMP)2 Cl2 ].H2 O .......... Diamagnetic Oh

So the complex has octahedral geometry. Such octahedral geometry is deduced from the µeff value which equals, 4.71 B.M [10,11]. However, the electronic absorption spectra of the buff manganese complex, [Mn(TMP)2Cl2].H2O, (Table 3), gave bands at 310, 353 and 500 nm where the first band is assigned to 6A1g→4A1g transition, while the second band is due to 6A1g→ 4T2g transition and the last band is due to 6A1g→4T1g transition [12,13]. Its room temperature µeff value of 4.30 B.M, typified the existence of Oh geometry. The electronic absorption spectra of pale brown iron complex, [Fe(TMP)Cl2(OH)H2O].2H2O, (Table 3), gave bands at 258, 350, 483 nm. These bands are due to CT (t2g → π*) and CT (π →eg). Its room temperature µeff value of 4.26 B.M, typified the existence of Oh configuration [14,15]. The spectra for the pale pink [Co(TMP)2Cl2].3H2O complex, (Table 3), gave bands at 294, 473, 558 nm. The bands are due to charge transfer, while the latter broad band is assigned to 4T1g(F)→4T1g(P) transition with µeff = 5.13 B.M, typified the existence of octahedral geometry [16]. The green electronic absorption spectra for the [Ni(TMP)2Cl2].H2O complex showed three bands at 381, 480 and 625 nm due to 3A2g(F)→3T1g(P) and 3A2g(F)→3T1g(F) transitions, respectively, (Table 3) with octahedral geometry , further deduced from the µeff value which equal 2.80 B.M. The pale green copper complex [Cu(TMP)2Cl2].H2O, (Table 3), exhibited bands at 260, 410 and 720 nm assigned to 2Eg → 2T2g transition suggesting octahedral geometry (Figure 3) [17], with room temperature µeff value 2.09 B.M.

Proposed structures of trimethoprim metal complexes.

Figure 3: Proposed structures of trimethoprim metal complexes.

The complexes of zinc, cadmium and mercury are diamagnetic with d10 configuration, so no d-d transition could be observed. The geometry of zinc, cadmium and mercury complexes was octahedral depending on elemental analysis.

Electron spin resonance of copper complex

The room temperature solid state ESR spectrum of [Cu(TMP)2Cl2].H2O complex (1:2),

X-band ESR spectra of [Cu (TMP)2 Cl2 ].H2 O complex.

Figure 4: X-band ESR spectra of [Cu (TMP)2 Cl2 ].H2 O complex.

Figure 4 exhibit an isotropic nature where gs = 2.173 with value of A = 148 (× 10-4 cm-1).

Biological activity

The antimicrobial activities of the synthesized complexes have been screened in vitro, as growth inhibiting agents. The antibacterial and antifungal screening were carried out using disc diffusion method [18] against some strains of bacteria like Staphylococcus aureas (ATCC 6538P), Bacillus subtilis (ATCC 19659); (Gram positive), Escherichia coli (ATCC 8739) and Pesudomonas aeruginosa (ATCC 9027); (Gram negative) and one fungal species Candida albicans (ATCC 2091). The compounds were dissolved in DMSO (1mg/ml). The study included trimethoprim and four complexes of different metal ions (cobalt, nickel, copper and zinc). Two different broadly antibiotics (Ciprofloxacin and Clotrimazole) are used in this study as references. After incubation for 24 h at 37°C in the case of bacteria and for 48 h at 37°C in the case of fungi, inhibition of the organisms was evidenced by clear zone surrounding each disk, measured in millimeters [19]. Trimethoprim and its all complexes showed high antimicrobial activity. The ligand showed inhibition zone 33 for Gram-positive bacteria (Staphylococcus aureus) and inhibition zone 30 for Gram negative bacteria (Escherichia coli)(Table 4).

Table 4: Antibacterial and antifungal activity of the investigated compounds against some reference strains expressed in absolute activity (AU).

Compound Blank Staphyllococcus aureus Bacillus subtilits Pseudomonas aeruginosa Escherichia coli Candida albicans
Trimethoprim 8 33 8 8 30 25
[Co(TMP)2 Cl2 ].3H2 O 8 29 8 8 27 17
[Ni(TMP)2 Cl2 ].H2 O 8 30 8 8 27 20
[Cu(TMP)2 Cl2 ].H2 O 8 30 8 8 24 20
[Zn(TMP)2 Cl2 ].H2 8 30 8 8 27 19
Ciprofloxacin 9 30 30 30 30 -
Clotrimazole 10 - - - - 17

Also, it showed antifungal effect with inhibition zone 25.The [Co(TMP)2Cl2].3H2O complex showed activity for Staphylococcus aureus and Escherichia colia with inhibition zones 29 and 27, respectively. The complex has also activity against Candida albicans with inhibition zone 17. The complexes [Ni(TMP)2Cl2].H2O, and [Zn(TMP)2Cl2].H2O showed activity for Staphylococcus aureus with inhibition zones 30. While for Escherichia coli the inhibition zones were 27.The [Cu(TMP)2Cl2]. H2O complex showed activity against Staphylococcus aureus and Escherichia coli with inhibition zones 30 and 24, respectively. Trimethoprim and its metal complexes showed no activity against Pesudomonas aeruginosa and Bacillus subtilits, while they appeared a well antifungal activity with Candida albicans (Table 4).

Thermal analysis

The thermal analysis of some coordination compounds has been reported from Masoud et al [20-24]. The study of thermal analysis of the ligand (trimethoprim) and its metal complexes were investigated. In this study different techniques were used: thermogravimetric analysis (TGA) and differential thermal analysis (DTA). The data of analysis are collected in Table 5.

Table 5: DTA analysis of trimethoprim and its metal complexes.

Compound Type Tm (°K) Ea kJ mol-1 n αm ?S# kJ K-1 mol-1 ?H# kJ mol-1 Z S-1 Temp. (°C) TGA Wt. Loss % Assignment
Calc Found
Trimethoprim Endo 487 6.38 1.19 0.60 -0.322 -156.71 0.002 36.6-255.5 255.5-401.7 9.64 42.02 9.21
42.01
Elimination of CH2 CH2 . Loss of CO2 and C6 H6 .
Endo 723 20.77 1.27 0.59 -0.319 -230.311 0.003 401.7-597.4 48.23 48.66 Elimination of the rest of ligand forming no residue.
[Cr(TMP)Cl2 (OH)H2 O]. H2 O Endo 345 9.27 1.26 0.59 -0.313 -107.97 0.003 20.9-232.0 13.72 12.91 Loss of 2H2 O and CH2 CH2 .
Exo 759 43.24 1.34 0.58 -0.313 -237.764 0.007 232.0-375.0
375.0-505.4
33.97 35.92 33.52
37.33
Loss of CO2 , C6 H6 and HCl. Elimination of the rest of ligand and forming 0.5Cr2 O3 .
[Mn(TMP)2 Cl2 ].H2 O Endo 366 22.07 1.52 0.55 -0.307 -112.26 0.007 32.1-237.8 55.32 55.88 Loss of H2 O,2HCl,2C6 H6 ,C2 H2 , 3CO and CH3 COH.
Exo 771 36.66 1.17 0.60 -0.315 -242.782 0.006 237.8-418.7 418.7-598.1 4.13 20.70 3.54 20.17 Elimination of N2 H2 . Elimination of the rest of ligand, forming MnO+6C.
[Fe(TMP)Cl2 (OH) H2 O].2H2 O Endo 358.4 10.01 2.18 0.48 -0.313 -112.162 0.003 35.8-201.2 11.06 10.99 Elimination of 3H2 O.
Exo 585 119.36 1.28 0.59 -0.300 -175.786 0.025 201.2-415.8 34.91 34.74 Elimination of 3C2 H2 ,HCl and 2CO.
Exo 801 33.01 1.02 0.63 -0.316 -253.436 0.005 415.8-565.1 37.57 38.07 Elimination of the rest of ligand, forming 0.5Fe2 O3 .
[Co(TMP)2 Cl2 ].3H2 O Endo 457 7.51 1.19 0.59 -0.319 -145.956 0.002 36.0-163.7 163.7-279.6 7.07 7.85 7.97 8.27 Elimination of 3H2 O. Elimination of 2H2 CO.
Exo 613 105.27 1.33 0.58 -0.302 -185.316 0.021 279.6-443.5 36.48 35.05 Elimination of Cl2 , 2CO and 2C6 H6 .
Exo 753.4 145.29 1.41 0.57 -0.303 -228.326 0.023 443.5-556.0 38.45 38.85 Elimination of the rest of ligand, forming CoO.

In case of the free ligand (trimethoprim), the decomposition occurred in three steps in temperature range 36.6-597.4ºC, Figure 5.

TGA and DTA curves for trimethoprim.

Figure 5: TGA and DTA curves for trimethoprim.

The first step of decomposition at 36.6ºC, the weight loss was 9.21%. The step ended at 255.5ºC. The second step of decomposition started above 256ºC and the weight loss was 42.02%, this step ended at 401.7ºC.While the last step was in temperature range between 402-600ºC, and the weight loss was 48.66%. All steps accompanied by the endothermic effect in the DTA curve in the range of temperature from 19.7 to 600ºC. All TGA steps were ended by no residue. The suggested mechanism of decomposition is given in Figure 6.

Thermolysis of Trimethoprim

Figure 6: Thermolysis of Trimethoprim

TGA and DTA curves for [Cr(TMP)Cl2 (OH)H2 O].H2 O complex.

Figure 7: TGA and DTA curves for [Cr(TMP)Cl2 (OH)H2 O].H2 O complex.

For the [Cr(TMP)Cl2(OH)H2O].H2O complex, Figure 7, the decomposition occurred in three steps. The first step of decomposition above 30ºC, the weight loss was 12.91% and ended at 232.0ºC which accompanied by the endothermic effect in the DTA curve at temperature 200ºC. The second step of decomposition started above 240 ºC and the weight loss was 33.52%, this step ended at 375ºC. While the last step was in temperature range between 380-505.4ºC, and the weight loss was 37.33%. The second and the last steps in TGA are overlapped to give an exothermic peak in DTA thermogram which appeared in temperature range 240-600ºC. The first endothermic peak is due to dehydration of water molecules and loss of ethylene. The rest strong peaks are due to decomposition steps of the complex ended with the formation of 0.5 Cr2O3 as a final product. The suggested mechanism of decomposition is given in Figure 8.

Thermolysis of [Cr(TMP)Cl2 (OH)H2 O].H2 O complex.

Figure 8: Thermolysis of [Cr(TMP)Cl2 (OH)H2 O].H2 O complex

Meanwhile, the [Hg(TMP)2Cl2].H2O complex, Figure 9, decomposed in three steps, there is no mass change to 35.9ºC.

TGA and DTA curves for [Hg(TMP)2 Cl2 ].H2 O complex

Figure 9: TGA and DTA curves for [Hg(TMP)2 Cl2 ].H2 O complex

the first step started at 36ºC , the weight loss was 56.51% and ended at 157.2ºC, this step accompanied by the endothermic effect in the DTA curve at temperature 89ºC.The second step of decomposition started above 158ºC and the weight loss was 15.45%. The step ended at 265.9ºC.The last step decomposed above 266ºC, and the weight loss was 25.09% and ended at 595.9ºC. The second and last steps accompanied by the exothermic effect in the DTA curve at temperature 332ºC. All TGA steps are due to dehydration process of water molecule, sublimation of Hg in temperature range 266-595.9°C and decomposition steps of the complex ended by formation of carbon residue as a final product with 2.8%. The suggested mechanism of decomposition is given in Figure 10.

Thermolysis of [Hg(TMP)2 Cl2 ].H2 O complex.

Figure 10: Thermolysis of [Hg(TMP)2 Cl2 ].H2 O complex.

Determination of Ea  by the relation of ln?T against 103 /T for trimethoprim ligand.

Figure 11: Determination of Ea by the relation of lnΔT against 103 /T for trimethoprim ligand.

CONCLUSION

The complexes of trimethoprim was synthesized and characterized by different spectroscopic methods. The stoichiometry of complexes was determined by the analytical data. All complexes have octahedral geometries. The Nujol mull electronic spectra confirmed these results. An ESR spectrum of copper complex was studied. The spectral data confirmed that trimethoprim acts as a bidentate ligand. Trimethoprim showed higher antibacterial and antimicrobial activity than the prepared complexes for some strains. The kinetic and thermodynamic parameters were calculated from the differential thermal analysis curves. All complexes were thermally decomposed and ended by formation of metal oxides except the complex of mercury.

REFERENCES

1. Rajith L, Kumar KG. The role of banned substance residue analysis in the control of dietary supplement contamination. Drug Testing and Analysis. 2010; 2: 436-441.

2. Brumfitt W, Hamilton-Miller JMT. Reassessment of the Rationale for the Combinations of Sulfonamides with Diaminopyrimidines. J Chemotherapy. 1993; 5: 465-469.

3. Lawrenson RA, Logie JW. Antibiotic failure in the treatment of urinary tract infections in young women. J Antimicrobial Chemotherapy. 2001; 48: 895-901.

4. Demirezen N, Tar?nç D, Polat D, Çe?me M, Gölcü A, Tümer M. Synthesis of trimethoprim metal complexes: Spectral, electrochemical, thermal, DNA-binding and surface morphology studies. Spectrochim Acta A. 2012; 94: 243-255.

5. Vogel AI. A Text Book of Quantitative Inorganic Analysis, Longmans, London. 1989.

6. Lee RH, Griswold E, Kleinberg. Studies on the Stepwise Controlled Decomposition of 2,2’-Bipyridine Complexes of Cobalt(II) and Nickel(II) Chlorides. J Inorg Chem. 1964; 3: 1278-1283.

7. Schwarzenbach G. Complexometric Titration, Translated by H, Methuen Co., London, Irving. 1957.

8. El-Asmy AA, Al-Hazmi GAA. Synthesis and spectral feature of benzophenone-substituted thiosemicarbazones and their Ni(II) and Cu(II) complexes. Spectrochimica Acta A. 2009; 71: 1885-1890. Figure 11 Determination of Ea by the relation of lnΔT against 103 /T for trimethoprim ligand.

9. Price ER,Wasson JR. Ligating, Spectral and Thermal Properties of Febuxostat Metal Complexes. J Inorg Nucl Chem. 1974; 36: 711-716.

10. Howlader MBH, Islam MS, Karim MR. Synthesis of some 16-membered macrocyclic complexes of chromium (III), manganese (II), iron(III), cobalt (II), nickel (II) and copper (II) containing a tetraoxooctaazacyclohexadecane ligand. J Chem. 2000; 39: 407 409.

11. Sreekanth A, Joseph M, Fun HK, Kurup MRP. Formation of manganese (II) complexes of substituted thiosemicarbazones derived from 2-benzoylpyridine: Structural and spectroscopic studies. Polyhedron. 2006; 25: 1408-1414.

12. Buhl F, Sroka BS. Desorption/Ionization on Silicon Time-of-Flight/ Time-of-Flight Mass Spectrometry. Chem Anal. 2003; 48: 58-145.

13. Thakar A, Joshi K, Pandya K, Pancholi A. Crystal structure of 2-(3-chloro-phenyl)-5-methyl-4-[1-(5-methyl-4-ptolyl-thiazol-2- ylimino)-ethyl]-2,4-dihydro-pyrazol-3-one, C23H21ClN4OS. J Chem. 2011; 8: 1750-1764.

14. Sokolov VI, Pustovarov VA, Churmanov VN, Ivanov VY, Gruzdev NB, Sokolov. Unusual x-ray excited luminescence spectra of NiO suggest self-trapping of the d-d charge-transfer exciton. JETP letters. 2012; 95: 528-533.

15. Lever ABP. Inorganic electronic spectroscopy. Elsevier publish Co, Amsterdam. 1968; 420.

16. Barefield EK, Busch DH, Nelson SM. The Effects of Metal Ion and Ligand Substitution on the Spectroscopic Properties of Metal Complexes. Quart Rev. 1968; 22: 457- 498.

17. Lokhande MV, Choudhary MR. Some transitional metal ions Complexes With 3-{[(E)-(4-fluorophenyl) methylidene] amino} benzoic acid and its Microbial Activity. Int J Pharm Sci Res. 2014; 5: 1757.

18. Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: A review: A Review. J Pharm Ana. 2016; 6: 71- 79.

19. Gull P, Hashmi AA. Biological Activity Studies on Metal Complexes of Macrocyclic Schiff Base Ligand: Synthesis and Spectroscopic Characterization. J Braz Chem Soc. 2017; 26: 1331-1337.

20. Masoud MS, Ali AE, Ahmed HM, Mohamed EA. Spectral studies and thermal analysis of new vanadium complexes of ethanolamine and related compounds. J Mol Str. 2013; 1050: 43-52.

21. Masoud MS, Ali AE, Elasala GS. Spectroscopic behavior and equilibrium studies of some metallocephalosporins. Spectrochim Acta A. 2015; 149: 363-377.

22. Masoud MS, Ali AE, Ghareeb DA, Nasr NM. Synthesis, characterization, spectral, thermal analysis and computational studies of thiamine complexes. J Mol Str. 2015; 1099: 359-372.

23. Masoud MS, Ali AE, Elasala GS, Kolkaila AS. J chem Pharm Res. Spectroscopic Studies and Thermal Analysis on Cefoperazone Metal Complexes. 2017; 9: 171-179.

24. Masoud M.S, Ali AE, Elasala GS, Kolkaila AS. Synthesis, spectroscopic, biological activity and thermal characterization of ceftazidime with transition metals. Spectrochim Acta A. 2018; 193: 458-466.

Masoud MS, Ali AE, Elasala GS, Amer GE (2019) Synthesis, Characterization, Biological Activity and Thermal Studies of Trimethoprim Metal Complexes. J Drug Des Res 6(1): 1074.

Received : 31 Dec 2018
Accepted : 24 Jan 2019
Published : 30 Jan 2019
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X